6-Bromo-3,4-dihydroquinazolin-2(1H)-one, 95.0%, 250mg

(S)-6,6'-Bis(bis(3,5-bis(trimethylsilyl)phenyl)phosphino)-2,2',3,3'-tetrahydro-5,5'-bibenzo[b][1,4]dioxine, 98%, 250mg

(R)-Hexahydropyrazino[2,1-c][1,4]oxazin-4(3H)-one hydrochloride, 95.0%, 250mg

(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 95.0%, 5g

3-(4-Methyl-4H-[1,2,4]triazol-3-yl)-phenylamine, 95.0%, 250mg

2-Bromo-3-dodecylthiophene>97.0%(GC)5g

4-Cyclopropyl-5-methyl-1,3-oxazol-2-amine, 95%, 250mg

(3-BROMO-5-CHLOROPYRIDIN-2-YL)METHANOL, 95.0%, 250mg

2-Methoxybenzoyl Chloride>98.0%(GC)(T)100g

1-(4-Chlorophenyl)-N-methylmethanamine hydrochloride, 95.0%, 1g

1-(2-Amino-4-methoxy-3-methylphenyl)ethanone, 95.0%, 1g

Talc, Ph.Eur., USP, poudre, environ 44 µm, 2,5 kg, emballage plastique.

4,6-Dichloro-3-methyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 100mg